NCT04241796View on ClinicalTrials.gov

Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice

NACompletedINTERVENTIONAL
Enrollment

6,662

Participants

Timeline

Start Date

December 12, 2019

Primary Completion Date

December 1, 2021

Study Completion Date

January 5, 2022

Conditions
Cancer
Interventions
DEVICE

Multi-Cancer Early Detection Test

Blood collection and multi-cancer early detection testing with return of results.

Trial Locations (11)

22031

Virginia Cancer Specialists, PC, Fairfax

32503

Woodlands Medical Specialists, PA, Pensacola

44195

Cleveland Clinic, Cleveland

55905

Mayo Clinic Rochester, Rochester

79106

Texas Oncology, PA (West TXO), Amarillo

84790

Intermountain Healthcare Research, St. George

95661

Sutter Health, Roseville

97201

Oregon Health & Science University, Portland

97401

Willamette Valley Cancer Institute, Eugene

98684

Northwest Cancer Specialists, P.C. dba Compass Oncology, Vancouver

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

GRAIL, Inc.

INDUSTRY

NCT04241796 - Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice | Biotech Hunter | Biotech Hunter